
GlaxoSmithKline

X
GSK’s Indian Horlicks sale may fetch over $4 billion
https://pharmaphorum.com/news/gsk-indian-horlicks-sell-might-fetch-4-billion/

X
GSK appoints former HSBC exec Iain Mackay as CFO
https://pharmaphorum.com/news/gsk-appoints-former-hsbc-exec-iain-mackay-cfo/

X
GSK signs $300m R&D deal with 23andMe
https://pharmaphorum.com/r-d/gsk-welcomes-23andmes-dna-database/

X
GSK could split amid pressure from investors – report
https://pharmaphorum.com/news/gsk-chairman-raises-break-prospect/

GSK’s blockbuster HIV drug linked with birth defects
Regulators issue warning after preliminary study findings
X
GSK’s blockbuster HIV drug linked with birth defects
https://pharmaphorum.com/news/gsk-blockbuster-hiv-drug-linked-with-birth-defects/

FDA approves expanded use for GSK’s COPD triple therapy
GSK is aiming to revive its respiratory drugs franchise
X
FDA approves expanded use for GSK’s COPD triple therapy
https://pharmaphorum.com/news/fda-approves-expanded-use-for-gsks-copd-triple-therapy/

X
GSK to pay $13bn for Novartis stake in OTC joint venture
https://pharmaphorum.com/news/gsk-wants-take-control-otc-joint-venture/

X
Verona to take COPD hopeful into phase 3
https://pharmaphorum.com/market-access-2/verona-to-take-copd-hopeful-into-phase-3/